Conformational stability as a design target to control protein aggregation.
暂无分享,去创建一个
Christopher J Roberts | A. Robinson | C. Roberts | Erik J Fernandez | Anne Skaja Robinson | K. Tiller | Joseph A Costanzo | Christopher J O'Brien | Kathryn Tiller | Erin Tamargo | C. O’Brien | J. Costanzo | E. Fernandez | E. Tamargo
[1] C. Dobson,et al. Protein unfolding, amyloid fibril formation and configurational energy landscapes under high pressure conditions. , 2006, Chemical Society reviews.
[2] Silvio C. E. Tosatto,et al. The PASTA server for protein aggregation prediction. , 2007, Protein engineering, design & selection : PEDS.
[3] Michele Vendruscolo,et al. Prediction of aggregation-prone regions in structured proteins. , 2008, Journal of molecular biology.
[4] B. Müller-Hill,et al. Strengthening the dimerisation interface of Lac repressor increases its thermostability by 40 deg. C. , 2000, Journal of molecular biology.
[5] O. Schueler‐Furman,et al. Progress in Modeling of Protein Structures and Interactions , 2005, Science.
[6] V. Eijsink,et al. Rational engineering of enzyme stability. , 2004, Journal of biotechnology.
[7] Paula Rahal,et al. Molecular models of NS3 protease variants of the Hepatitis C virus , 2005, BMC Structural Biology.
[8] J. King,et al. Folding and stability of the isolated Greek key domains of the long‐lived human lens proteins γD‐crystallin and γS‐crystallin , 2007, Protein science : a publication of the Protein Society.
[9] Roland L. Dunbrack,et al. Bayesian statistical analysis of protein side‐chain rotamer preferences , 1997, Protein science : a publication of the Protein Society.
[10] A. Robinson,et al. Maximizing Recovery of Native Protein from Aggregates by Optimizing Pressure Treatment , 2008, Biotechnology progress.
[11] Stephen J. Wright,et al. Optimal design of thermally stable proteins , 2008, Bioinform..
[12] S. Ray,et al. Engineered disulfide bonds restore chaperone-like function of DJ-1 mutants linked to familial Parkinson's disease. , 2010, Biochemistry.
[13] D. Baker,et al. A large scale test of computational protein design: folding and stability of nine completely redesigned globular proteins. , 2003, Journal of molecular biology.
[14] W. Gombotz,et al. Minimization of recombinant human Flt3 ligand aggregation at the Tm plateau: a matter of thermal reversibility. , 1999, Biochemistry.
[15] D. Foguel,et al. Hydrostatic pressure rescues native protein from aggregates. , 1999, Biotechnology and bioengineering.
[16] Xiaozhen Hu,et al. Computer-based redesign of a beta sandwich protein suggests that extensive negative design is not required for de novo beta sheet design. , 2008, Structure.
[17] J F Brandts,et al. A simple model for proteins with interacting domains. Applications to scanning calorimetry data. , 1989, Biochemistry.
[18] V. Eijsink,et al. Directed evolution of enzyme stability. , 2005, Biomolecular engineering.
[19] Michele Vendruscolo,et al. Prediction of "aggregation-prone" and "aggregation-susceptible" regions in proteins associated with neurodegenerative diseases. , 2005, Journal of molecular biology.
[20] William F. Weiss,et al. Computational design and biophysical characterization of aggregation-resistant point mutations for γD crystallin illustrate a balance of conformational stability and intrinsic aggregation propensity. , 2011, Biochemistry.
[21] Jeffery G Saven,et al. Computational protein design: Advances in the design and redesign of biomolecular nanostructures. , 2010, Current opinion in colloid & interface science.
[22] J. King,et al. Contributions of hydrophobic domain interface interactions to the folding and stability of human γD‐crystallin , 2005, Protein science : a publication of the Protein Society.
[23] J. Carpenter,et al. Partial molar volume, surface area, and hydration changes for equilibrium unfolding and formation of aggregation transition state: High-pressure and cosolute studies on recombinant human IFN-γ , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[24] J. King,et al. Molecular basis of a progressive juvenile-onset hereditary cataract. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[25] Wei Wang,et al. Protein aggregation--pathways and influencing factors. , 2010, International journal of pharmaceutics.
[26] John F. Carpenter,et al. Physical Stability of Proteins in Aqueous Solution: Mechanism and Driving Forces in Nonnative Protein Aggregation , 2003, Pharmaceutical Research.
[27] Pu Tian. Computational protein design, from single domain soluble proteins to membrane proteins. , 2010, Chemical Society reviews.
[28] Christopher J Roberts,et al. Comparative effects of pH and ionic strength on protein-protein interactions, unfolding, and aggregation for IgG1 antibodies. , 2010, Journal of pharmaceutical sciences.
[29] Christopher J Roberts,et al. Non‐native protein aggregation kinetics , 2007, Biotechnology and bioengineering.
[30] Geoffrey K. Hom,et al. Full-sequence computational design and solution structure of a thermostable protein variant. , 2007, Journal of molecular biology.
[31] C. Pace. Determination and analysis of urea and guanidine hydrochloride denaturation curves. , 1986, Methods in enzymology.
[32] María Vázquez-Rey,et al. Aggregates in monoclonal antibody manufacturing processes , 2011, Biotechnology and bioengineering.
[33] Christopher J Roberts,et al. A Lumry-Eyring nucleated polymerization model of protein aggregation kinetics: 1. Aggregation with pre-equilibrated unfolding. , 2007, The journal of physical chemistry. B.
[34] Huub Schellekens,et al. Structure-Immunogenicity Relationships of Therapeutic Proteins , 2004, Pharmaceutical Research.
[35] B. Kuhlman,et al. Structure-based protocol for identifying mutations that enhance protein-protein binding affinities. , 2007, Journal of molecular biology.
[36] Dusan Bratko,et al. Protein aggregation in silico. , 2007, Trends in biotechnology.
[37] M. James C. Crabbe,et al. Protein Folds and Functional Similarity; the Greek Key/immunoglobulin Fold , 1995, Comput. Chem..
[38] Melissa S Kosinski-Collins,et al. Interdomain side‐chain interactions in human γD crystallin influencing folding and stability , 2005, Protein science : a publication of the Protein Society.
[39] Regina M Murphy,et al. Peptide aggregation in neurodegenerative disease. , 2002, Annual review of biomedical engineering.
[40] Hanns-Christian Mahler,et al. Protein aggregation: pathways, induction factors and analysis. , 2009, Journal of pharmaceutical sciences.
[41] J. King,et al. Formation of amyloid fibrils in vitro by human γD-crystallin and its isolated domains , 2008, Molecular vision.
[42] Huub Schellekens,et al. Oxidized and Aggregated Recombinant Human Interferon Beta is Immunogenic in Human Interferon Beta Transgenic Mice , 2011, Pharmaceutical Research.
[43] M. Karplus,et al. Effective energy function for proteins in solution , 1999, Proteins.
[44] R. Fernández-Lafuente. Stabilization of multimeric enzymes: Strategies to prevent subunit dissociation , 2009 .
[45] Francesc X. Avilés,et al. AGGRESCAN: a server for the prediction and evaluation of "hot spots" of aggregation in polypeptides , 2007, BMC Bioinform..
[46] David Baker,et al. Macromolecular modeling with rosetta. , 2008, Annual review of biochemistry.
[47] Wei Wang,et al. Protein aggregation and its inhibition in biopharmaceutics. , 2005, International journal of pharmaceutics.
[48] George I Makhatadze,et al. Protein stability and surface electrostatics: a charged relationship. , 2006, Biochemistry.
[49] Yi Lu,et al. Design of functional metalloproteins , 2009, Nature.
[50] V. Uversky,et al. SS-Stabilizing Proteins Rationally: Intrinsic Disorder-Based Design of Stabilizing Disulphide Bridges in GFP , 2012, Journal of biomolecular structure & dynamics.
[51] Eric A. Althoff,et al. De Novo Computational Design of Retro-Aldol Enzymes , 2008, Science.
[52] William F Weiss,et al. Principles, approaches, and challenges for predicting protein aggregation rates and shelf life. , 2009, Journal of pharmaceutical sciences.
[53] Amedeo Caflisch,et al. Prediction of aggregation rate and aggregation‐prone segments in polypeptide sequences , 2005, Protein science : a publication of the Protein Society.
[54] L. Serrano,et al. Protein aggregation and amyloidosis: confusion of the kinds? , 2006, Current opinion in structural biology.
[55] J. King,et al. Probing folding and fluorescence quenching in human γD crystallin Greek key domains using triple tryptophan mutant proteins , 2004, Protein science : a publication of the Protein Society.
[56] Thomas E. Creighton,et al. Protein structure : a practical approach , 1997 .
[57] BMC Bioinformatics , 2005 .
[58] Robert H. Brown,et al. An intersubunit disulfide bond prevents in vitro aggregation of a superoxide dismutase-1 mutant linked to familial amytrophic lateral sclerosis. , 2004, Biochemistry.
[59] Andreas Plückthun,et al. Consensus Design of Repeat Proteins , 2004, Chembiochem : a European journal of chemical biology.
[60] Salvador Ventura,et al. Prediction of "hot spots" of aggregation in disease-linked polypeptides , 2005, BMC Structural Biology.
[61] Melissa S Kosinski-Collins,et al. In vitro unfolding, refolding, and polymerization of human γD crystallin, a protein involved in cataract formation , 2003, Protein science : a publication of the Protein Society.
[62] B. García-Moreno E.,et al. Changes in stability upon charge reversal and neutralization substitution in staphylococcal nuclease are dominated by favorable electrostatic effects. , 2003, Biochemistry.
[63] Anne S De Groot,et al. Immunogenicity of protein therapeutics. , 2007, Trends in immunology.
[64] Yi Liu,et al. RosettaDesign server for protein design , 2006, Nucleic Acids Res..
[65] A. Plückthun,et al. Different equilibrium stability behavior of ScFv fragments: identification, classification, and improvement by protein engineering. , 1999, Biochemistry.
[66] J. Kelly,et al. R104H may suppress transthyretin amyloidogenesis by thermodynamic stabilization, but not by the kinetic mechanism characterizing T119 interallelic trans-suppression , 2006, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[67] Amedeo Caflisch,et al. Computational models for the prediction of polypeptide aggregation propensity. , 2006, Current opinion in chemical biology.
[68] A. Plückthun,et al. New protein engineering approaches to multivalent and bispecific antibody fragments. , 1997, Immunotechnology : an international journal of immunological engineering.
[69] Fred Jacobson,et al. Protein aggregation and bioprocessing , 2006, The AAPS Journal.
[70] M. Lehmann,et al. Engineering proteins for thermostability: the use of sequence alignments versus rational design and directed evolution. , 2001, Current opinion in biotechnology.
[71] L. Serrano,et al. Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins , 2004, Nature Biotechnology.
[72] 김삼묘,et al. “Bioinformatics” 특집을 내면서 , 2000 .
[73] Tim J Kamerzell,et al. Protein-excipient interactions: mechanisms and biophysical characterization applied to protein formulation development. , 2011, Advanced drug delivery reviews.
[74] A. Fink. Protein aggregation: folding aggregates, inclusion bodies and amyloid. , 1998, Folding & design.
[75] Brian Kuhlman,et al. Structure-based design of supercharged, highly thermoresistant antibodies. , 2012, Chemistry & biology.
[76] R. Wetzel,et al. Breakdown in the relationship between thermal and thermodynamic stability in an interleukin-1 beta point mutant modified in a surface loop. , 1993, Protein engineering.
[77] D. Kalonia,et al. Temperature- and pH-Induced Multiple Partially Unfolded States of Recombinant Human Interferon-α2a: Possible Implications in Protein Stability , 2003, Pharmaceutical Research.
[78] J Pierard,et al. Amyloid , 2023, Arthritis and rheumatism.
[79] T. Arakawa,et al. Effect of additives on protein aggregation. , 2009, Current pharmaceutical biotechnology.
[80] R. Wetzel. Mutations and off-pathway aggregation of proteins. , 1994, Trends in biotechnology.
[81] A. Plückthun,et al. Stability engineering of antibody single-chain Fv fragments. , 2001, Journal of molecular biology.
[82] Babatunde A. Ogunnaike,et al. Multi-variate approach to global protein aggregation behavior and kinetics: effects of pH, NaCl, and temperature for alpha-chymotrypsinogen A. , 2010, Journal of pharmaceutical sciences.
[83] C. Pace,et al. Substrate stabilization of lysozyme to thermal and guanidine hydrochloride denaturation. , 1980, Journal of Biological Chemistry.
[84] D. Baker,et al. An orientation-dependent hydrogen bonding potential improves prediction of specificity and structure for proteins and protein-protein complexes. , 2003, Journal of molecular biology.
[85] Igor N. Berezovsky,et al. Entropic Stabilization of Proteins and Its Proteomic Consequences , 2005, PLoS Comput. Biol..
[86] Angela M. Gronenborn,et al. The Structure of the Cataract-Causing P23T Mutant of Human γD-Crystallin Exhibits Distinctive Local Conformational and Dynamic Changes†,‡ , 2009, Biochemistry.
[87] J. King,et al. Glutamine Deamidation Destabilizes Human γD-Crystallin and Lowers the Kinetic Barrier to Unfolding* , 2006, Journal of Biological Chemistry.
[88] George I Makhatadze,et al. Contribution of surface salt bridges to protein stability: guidelines for protein engineering. , 2003, Journal of molecular biology.
[89] G Vriend,et al. Structural and mutagenesis studies of leishmania triosephosphate isomerase: a point mutation can convert a mesophilic enzyme into a superstable enzyme without losing catalytic power. , 1999, Protein engineering.
[90] R. Rosenfeld. Nature , 2009, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[91] A. Plückthun,et al. Mutual stabilization of VL and VH in single-chain antibody fragments, investigated with mutants engineered for stability. , 1998, Biochemistry.
[92] Dusan Bratko,et al. Molecular simulation of protein aggregation , 2007, Biotechnology and bioengineering.
[93] M. Goldberg,et al. The renaturation of reduced chymotrypsinogen A in guanidine HCl. Refolding versus aggregation. , 1978, The Journal of biological chemistry.
[94] Vladimir I Razinkov,et al. Native-state solubility and transfer free energy as predictive tools for selecting excipients to include in protein formulation development studies. , 2012, Journal of pharmaceutical sciences.
[95] F. Young. Biochemistry , 1955, The Indian Medical Gazette.